Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Reproterol

A short-acting beta-2 agonist bronchodilator, patented in 1965 and in medical use since 1977 for asthma, by inhalation or intravenously. This family brings together the active ingredient, labelled standards and nitrosamines.

Did you know?Its molecule joins a theophylline scaffold and a beta-sympathomimetic part into a single piece, yet it acts only as a beta-2 agonist.

ReproterolGo to the active ingredient →
ReproterolActive ingredientReproterolCat. No. P-R036-001CAS 54063-54-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.